The pros and cons of hydroxyethyl starch solutions

Anesthesia and Analgesia

Volumn 104, Issue 3, 2007, Pages 484-486

  Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GELATIN; HETASTARCH; INTERLEUKIN 1; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTERIAL GAS; BLOOD CLOTTING; BLOOD CLOTTING DISORDER; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CLINICAL TRIAL; COLLOID; CRITICALLY ILL PATIENT; CRYSTALLOID; DRUG CLEARANCE; EDITORIAL; FLUID RESUSCITATION; HEMODYNAMICS; HUMAN; INFLAMMATION; INTRAVASCULAR SPACE; KIDNEY FAILURE; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE OXYGENATION;

ALBUMINS; ANIMALS; ANTI-INFLAMMATORY AGENTS; COLLOIDS; EMERGENCY MEDICINE; HETASTARCH; HUMANS; HYPERTONIC SOLUTIONS; PLASMA SUBSTITUTES; RESUSCITATION; SHOCK, SEPTIC; UNITED STATES; VASODILATOR AGENTS;

EID: 33847187385     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/01.ane.0000258224.44806.dd     Document Type: Editorial

References (33)

1. Symington BE. Hetastarch and bleeding complications. Ann Intern Med 1986;105:627-8.
2. Treib J, Haass A, Pindur G. Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997;78:974-83.
3. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet 1993;342:248-9.
4. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996;348:1620-2.
5. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6.
6. Thompson WL, Fukushima T, Rutherford RB, Walton RP. Intravascular persistence, tissue storage, and excretion of hydroxyethyl starch. Surg Gynecol Obstet 1970;131:965-72.
7. Bork K. Pruritus precipitated by hydroxyethyl starch: a review. Br J Dermatol 2005;152:3-12.
8. Treib J, Baron JF, Grauer MT, Strauss RG. An international view of hydroxyethyl starches. Intensive Care Med 1999;25:258-68.
9. Treib J, Haass A, Pindur G, et al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996;36:450-5.
10. Zikria BA, Subbarao C, Oz MC, et al. Macromolecules reduce abnormal microvascular permeability in rat limb ischemia-reperfusion injury. Crit Care Med 1989;17:1306-9.
11. Zikria BA, King TC, Stanford J, Freeman HP. A biophysical approach to capillary permeability. Surgery 1989;105:625-31.
12. Vincent JL. Plugging the leaks? New insights into synthetic colloids. Crit Care Med 1991;19:316-8.
13. Feng X, Liu J, Yu M, et al. Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage. Anesth Analg 2007;104:624-30.
14. Tian J, Lin X, Guan R, Xu JG. The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms. Anesth Analg 2004;98:768-74.
15. Schmand JF, Ayala A, Morrison MH, Chaudry IH. Effects of hydroxyethyl starch after trauma-hemorrhagic shock: restoration of macrophage integrity and prevention of increased circulating IL-6 levels. Crit Care Med 1995;23:806-14.
16. Handrigan MT, Burns AR, Donnachie EM, Bowden RA. Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration. Shock 2005;24:434-9.
17. Hoffmann JN, Vollmar B, Laschke MW, et al. Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002;97:460-70.
18. Jaeger K, Heine J, Ruschulte H, et al. Effects of colloidal resuscitation fluids on the neutrophil respiratory burst. Transfusion 2001;41:1064-8.
19. Dieterich HJ, Weissmuller T, Rosenberger P, Eltzschig HK. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Crit Care Med 2006;34:1775-82.
20. Boldt J, Ducke M, Kumle B, et al. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intensive Care Med 2004;30:416-22.
21. Marx G, Pedder S, Smith L, et al. Resuscitation from septic shock with capillary leakage: hydroxyethyl starch (130 kd), but not Ringer's solution maintains plasma volume and systemic oxygenation. Shock 2004;21:336-41.
22. Ali MH, Schlidt SA, Hynes KL, et al. Prolonged hypoxia alters endothelial barrier function. Surgery 1998;124:491-7.
23. Levy MM, Macias WL, Vincent JL, et al. Early changes in organ function predict eventual survival in severe sepsis. Crit Care Med 2005;33:2194-201.
24. Claridge JA, Schulman AM, Young JS. Improved resuscitation minimizes respiratory dysfunction and blunts interleukin-6 and nuclear factor-kappa B activation after traumatic hemorrhage. Crit Care Med 2002;30:1815-9.
25. Kiang JG, Lu X, Tabaku LS, et al. Resuscitation with lactated Ringer solution limits the expression of molecular events associated with lung injury after hemorrhage. J Appl Physiol 2005;98:550-6.
26. Anning PB, Finney SJ, Singh S, et al. Fluids reverse the early lipopolysaccharide-induced albumin leakage in rodent mesenteric venules. Intensive Care Med 2004;30:1944-9.
27. Wilson MA, Chou MC, Spain DA, et al. Fluid resuscitation attenuates early cytokine mRNA expression after peritonitis. J Trauma 1996;41:622-7.
28. Zhang C, Hsueh W, Caplan MS, Kelly A. Platelet activating factor-induced shock and intestinal necrosis in the rat: role of endogenous platelet-activating factor and effect of saline infusion. Crit Care Med 1991;19:1067-72.
29. Sakr Y, Dubois MJ, De Backer D, et al. Persistent microcirculatory alterations are associated with organ failure and death in patients with septic shock. Crit Care Med 2004;32:1825-31.
30. Zhang WJ, Frei B. Albumin selectively inhibits TNF alpha-induced expression of vascular cell adhesion molecule-1 in human aortic endothelial cells. Cardiovasc Res 2002;55:820-9.
31. Powers KA, Kapus A, Khadaroo RG, et al. Twenty-five percent albumin prevents lung injury following shock/resuscitation. Crit Care Med 2003;31:2355-63.
32. Simpkins CO, Little D, Brenner A, et al. Heterogeneity in the effect of albumin and other resuscitation fluids on intracellular oxygen free radical production. J Trauma 2004;56:548-58.
33. Quinlan GJ, Mumby S, Martin GS, et al. Albumin influences total plasma antioxidant capacity favorably in patients with acute lung injury. Crit Care Med 2004;32:755-9.